DiaCarta partners with OncoAssure for prostate cancer test commercialization
DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.
United States Adam Aiguo Zhang Ucd Research Centers For Medicare Medicaid Services Diacarta Inc Oncoassure Ltd
Source: news-medical.net